Procter & Gamble Co Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
4.3%projected annual EPS growth
Analyst Coverage
23analysts covering
FY Revenue (est.)
$88.7Bnext fiscal year
FY EPS (est.)
$6.99next fiscal year
Monitoring Framework
Key Performance Indicators
Organic Sales Growth Quarterly300.0%Target: 3% to 5%
Core Diluted Earnings Per Share (EPS) Growth Quarterly300.0%Target: FY2027 core EPS of $6.89–$7.11 (in-line to +3% growth vs. FY2026 core EPS of $6.89); prior FY2026 guidance was $6.83–$7.09 (in-line to +4%)
Adjusted Free Cash Flow Productivity Quarterly102.0Target: 90%+
Watch Items
- Input cost inflation headwinds — approximately $1 billion after-tax from higher raw materials, energy and transportation costs in fiscal 2027 (an ~8% drag on core EPS growth combined with interest, non-operating income and FX headwinds) — and their impact on gross marginAction: Reassess FY2026 margin and Core EPS assumptions each quarter; if commodity, tariff and restructuring cost headwinds are not being offset by productivity savings as guided, trim the base-case earnings estimates and revisit position sizing.
- Execution of the two-year portfolio and productivity restructuring plan — $1 to $1.6 billion in before-tax non-core restructuring costs (remainder to be incurred in fiscal 2027), including a 30–50 basis point organic sales headwind from brand, product form and go-to-market discontinuationsTrigger: Fiscal 2026 diluted EPS growth tracking below 1%, the low end of management's revised 1%-6% guidance range
Research as of 2 Sep 2026